Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation

Amiodarone can induce TdP; therefore, it should be avoided as a first choice for therapy in patients without heart disease. Careful QT interval monitoring, especially during intravenous use, can prevent development of this life-threatening arrhythmia.

Automated summary

Amiodarone should be avoided as a first-line therapy in patients without heart disease due to its potential to induce TdP. Careful monitoring of QT interval, particularly during intravenous administration, can help prevent the development of this life-threatening arrhythmia.